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The protein methylome in mammalian mitochondria has been little studied
until recently. Here, we describe that lysine-368 of human citrate synthase is
methylated and that the modifying enzyme, localized in the mitochondrial
matrix, is methyltransferase-like protein 12 (METTL12), a member of the
family of 7b-strand methyltransferases. Lysine-368 is near the active site of
citrate synthase, but removal of methylation has no effect on its activity. In
mitochondria, it is possible that some or all of the enzymes of the citric acid
cycle, including citrate synthase, are organized in metabolons to facilitate the
channelling of substrates between participating enzymes. Thus, possible roles
for the methylation of Lys-368 are in controlling substrate channelling itself,
or in influencing protein–protein interactions in the metabolon.
Keywords: citrate synthase; metabolons; METTL12; mitochondria;
protein methylation; substrate channelling
The methylation of lysine and arginine residues in non-
histone proteins is being associated increasingly with the
regulation of many different cellular activities [1,2].
Lysine residues can also be ubiquitinated and sumoy-
lated, and the interplay between methylation, acetyla-
tion and these other post-translational modifications, at
the same and neighbouring sites, adds complexity to the
regulation of biological processes by post-translational
modification [3–5]. Trimethylation of a lysine residue in
mitochondrial apocytochrome c by Ctm1p in the
cytoplasm of Saccharomyces cerevisiae is well known
[6,7], although the mammalian orthologue is unmodi-
fied. Methylation of yeast cytochrome c promotes its
import into the mitochondrial intermembrane space of
yeast mitochondria, and modulates its interaction with
other proteins [8,9]. Four other major mitochondrial
proteins have been reported to contain trimethylated
lysines. They are citrate synthase [10] and the b-subunit
of the electron transfer flavoprotein (ETFb) [11], both
found in the mitochondrial matrix, the ADP/ATP
Abbreviations
ASMTL, acetylserotonin O-methyltransferase-like; COMTD1, catechol O-methyltransferase domain-containing protein 1; Ctm1p, cytochrome
c methyltransferase; ECE2, Endothelin-converting enzyme 2; EFM4, elongation factor methyltransferase 4; ETD, electron transfer dissocia-
tion; ETFb, b-subunit of the electron transfer flavoprotein; HAP1, human haploid cell line 1; HEK, human embryonic kidney; HEMK1, heme
biosynthesis gene K methyltransferase family member 1; KMT2A, histone-lysine N-methyltransferase 2A; METTL10, methyltransferase-like
protein 10; METTL12, methyltransferase-like protein 12; METTL13, methyltransferase-like protein 13; METTL9, methyltransferase-like pro-
tein 9; MTRF1L, mitochondrial translation release factor 1-like; MTS, mitochondrial targeting sequence; NDUFAF7, NADH dehydrogenase
(ubiquinone) complex I assembly factor 7; NDUFB3, NADH dehydrogenase (ubiquinone) 1b subcomplex subunit 3; NDUFS2, NADH dehydro-
genase (ubiquinone) iron–sulphur protein 2; PRDM15, positive regulatory domain-containing protein 15; PRMT8, protein arginine methyltrans-
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containing protein 1; SAM, S-adenosyl-methionine; SET, SET domain (Drosophila Su(var)3-9, Enhancer of zeste and Trithorax); SETD4, SET
domain-containing protein 4; TOM and TIM, translocases of the outer and inner mitochondrial membranes respectively.
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translocase [12] and the c-subunit in the rotor of the
ATP synthase [13], both major components of the inner
mitochondrial membrane. Two additional proteins are
methylated in complex I. An arginine residue in the
NDUFS2 subunit is symmetrically dimethylated [14],
and three histidine residues near to the N terminus of
the NDUFB3 subunit are methylated to varying extents
[15]. In addition to these sites characterized in proteins
purified from mitochondria, other human proteins that
locate to mitochondria have been reported in cell-wide
methylome studies to contain methylated lysine and
arginine residues [16–18].
The methylation of proteins and RNA molecules is
catalysed by methyltransferases with S-adenosyl-
methionine as the methyl donor [19,20]. Until recently,
the only human methyltransferases known to be
located in mitochondria were HEMK1, which methy-
lates a glutamine residue in the mitochondrial transla-
tion release factor MTRF1L [21], and NDUFAF7, an
assembly factor for complex I [22]. In a continuing
systematic study of protein methylases in human mito-
chondria, we have shown that NDUFAF7 symmetri-
cally dimethylates Arg-85 in the NDUFS2 subunit of
complex I, and that this modification is an essential
step in the assembly of the complex [23]. We have also
demonstrated that METTL20 methylates lysine resi-
dues adjacent to the recognition loop of ETFb [11].
HEMK1, NDUFAF7 and METTL20 are all members
of the cell-wide protein family of 7b-strand methyl-
transferases. This family is characterized by a common
core similar to a Rossman fold with a twisted seven-
stranded b-sheet structure and usually six associated a-
helices, although the number of a-helices varies
[19,20]. Another member of the family, NDUFAF5,
also located in the matrix of mitochondria, hydroxy-
lates Arg-73 in subunit NDUFS7 of complex I [24].
This modification is an essential early step in the
assembly of the complex. Previously, we have con-
firmed that another 7b-strand methyltransferase,
METTL12, is found in the matrix of the organelle
[11]. Here, we demonstrate that METTL12 modifies
Lys-368 of citrate synthase in an external surface
region close to its catalytic site.
Materials and methods
Bioinformatic analyses
The presence of N-terminal mitochondrial targeting
sequences (MTSs) in the 208 known and putative methyl-
transferases [25] was examined with MitoProt, iPSORT, Tar-
getP and MitoFates [26–29]. The secondary structures of
proteins were predicted with Jpred [30] and PSIPRED [31].
Cell culture
Parental human embryonic kidney cells (HEK293T) and
the same cells overexpressing METTL12 were grown under
an atmosphere of 5% CO2 at 37 °C in high glucose
(25 mM) Dulbecco’s modified Eagle medium (DMEM) sup-
plemented with tetracycline-free FBS (10% v/v), penicillin
(100 unitsmL1) and streptomycin (0.1 mgmL1). The
medium also included blasticidin (15 lgmL1) and Zeocin
(100 lgmL1), or blasticidin (15 lgmL1) and hygromy-
cin (100 lgmL1) respectively. A human haploid cell line,
HAP1 (Horizon Discovery), derived from a chronic myel-
ogenous leukaemia, was grown at 37 °C in the presence of
5% CO2 in Iscove’s modified Dulbecco’s medium (IMDM)
containing 10% (v/v) FBS, penicillin (100 unitsmL1) and
streptomycin (0.1 mgmL1). A cell line, HAP1-DMETTL
12 (Horizon Discovery HZGHC000536c011), derived from
the parental cells by disruption of METTL12 by CRISPR-
Cas9 technology was grown under the same conditions.
The proliferation of cells was assayed at 37 °C in a humidi-
fied atmosphere containing 5% CO2 with an IncuCyte HD
instrument (Essen Bioscience, Welwyn Garden City, UK).
Initially, 1 9 105 parental HAP1 cells or HAP1-
DMETTL12 cells were seeded into three wells in a six-well
plate. Cell proliferation was followed by measuring conflu-
ence over a period of time and quantified with INCUCYTE
software (version 2011A; Essen Bioscience).
Expression of tagged METTL12
The cDNA for human METTL12 (Source BioScience,
Cambridge, UK) was amplified by PCR with the forward
and reverse primers 50-ACCGAGCTCGGATCCG-
GAATGGCCGCGCTGCGTCGAAT-30 and 50-ACCGGT
TCCCTCGAGATGAGAGCCTTGAATCAAGTAAG-30,
respectively, which introduced Flag and Strep II tags at its
C terminus. The amplified sequence was cloned into plas-
mid pcDNA5/FRT/TO. This plasmid and plasmid pOG44
were cotransfected in the presence of lipofectamine 2000
(Life Technologies, Paisley, UK) into human HEK293T
Flp-In T-Rex cells (total DNA 1 lg; pOG44:pcDNA5/
FRT/TO, 7 : 1 by weight) (Life Technologies) [32]. After
24 h, the cells were transferred into selective medium con-
taining blasticidin (15 lgmL1) and hygromycin
(100 lgmL1), and inducible cell lines expressing the
recombinant protein were selected. Expression of tagged
METTL12 was induced for 24 h with doxycycline
(20 ngmL1), then mitochondria [32] or mitoplasts [11,33]
were prepared from the cells.
Protein analyses
Samples of proteins were fractionated by SDS/PAGE on
Novex 10–20% acrylamide gradient gels (Life Technologies)
and then transferred by electrophoresis to Immobilon P
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membranes (Millipore, Watford, UK). Membranes were
washed with a solution (PBST) made from PBS containing
Tween-20 (0.01%, v/v), and then blocked with a solution of
dried skimmed milk in PBST, or, when a methyl-specific
antibody was used, in PBST plus bovine serum albumin.
Then, the membrane was exposed to the primary antibody.
The primary antibodies were specific for methyllysine and
trimethyllysine (Abcam, Cambridge, UK; ab23366 and
ab76118), human mitochondrial malate dehydrogenase,
citrate synthase and ETFb (Proteintech, Manchester, UK;
15462-1-AP, 16131-1-AP and 17925-1-AP respectively).
Bound primary antibodies were detected by chemilumines-
cence generated with an anti-rabbit secondary antibody con-
jugated to horse radish peroxidase (Thermo Fisher Scientific,
Loughborough, UK) and ECL prime reagents (GE Health-
care, Little Chalfont, UK). Bound proteins were stained with
Coomassie Blue R250 0.08% (w/v) dye dissolved in an aque-
ous solution containing 20% methanol (v/v) and 2.8% acetic
acid (v/v). The membrane was washed with 50% methanol
(v/v) and dried in air. Then it was wetted with 100% metha-
nol and reprobed with another antibody.
Mass spectrometry
Samples were fractionated by SDS/PAGE as above, and
proteins were detected by staining with Coomassie blue
dye. The stained bands were excised, digested ‘in-gel’ [34]
with trypsin or AspN protease, and the peptides were anal-
ysed in an LTQ OrbiTrap XL-electron transfer dissociation
(ETD) mass spectrometer (Thermo Scientific, Hemel Hemp-
stead, UK) coupled with a Proxeon Easy-nLC (Thermo
Scientific) for nanoscale reverse-phase peptide separation,
as described before [11,23]. Proteins were identified by
interrogation of a human protein sequence database with
the peptide mass and fragmentation data, with the aid of
Proteome Discoverer 1.3 (Thermo Scientific) and the Mas-
cot search engine, version 2.4.0 [35]. The identities of pep-
tides containing methylated lysine residues, and the specific
site of methylation, were determined by manual interpreta-
tion of ETD fragmentation data. Fragment ions generated
by ETD are labelled as c and z-ions, with the related z+H-
ions included with z-ions [36]. The relative abundances of
peptides bearing one, two, three or no methyl groups were
determined with Xcalibur data analysis software from cal-
culated peak areas of Gaussian smoothed extracted ion
chromatograms, applying a 5 p.p.m. m/z tolerance and
overlapping peptide retention times.
Assay of citrate synthase
The activity of citrate synthase in parental HAP1 cells and
HAP1-DMETTL12 cells was determined by an immunocap-
ture-based microplate assay (Abcam) requiring the mea-
surement of thionitrobenzoic acid released by the reaction
of 5,5-dithiobis-(2-nitrobenzoic acid) with CoA-SH
produced by the enzymic generation of citrate from
oxaloacetate and acetyl-CoA [37]. The concentration of
citrate synthase in cell lysates was determined with an
ELISA assay kit (Elabscience, Wuhan, China). Both assays
were performed in a Spectramax Plus 384 microplate reader
(Molecular Devices, Wokingham, UK), and analysed with
SOFTMAX PRO software (Molecular Devices).
Immunocapture of citrate synthase
Mitochondria from wild-type HAP1 cells and HAP1-
DMETTL12 cells, were solubilized at a protein concentra-
tion of 5 mgmL1 with 1% (w/v) dodecylmaltoside pre-
pared in PBS containing complete protease inhibitors
(Roche, Mannheim, Germany). An anti-citrate synthase
monoclonal antibody (Abcam ab128564) was added (5 lL
per 100 lL of mitochondrial solution), and the sample was
kept at 4 °C for 4 h. A 50% (w/v) slurry of protein-G agar-
ose (10 lL; Abcam) was added, and the sample was mixed
for 4 h at 4 °C. Unbound material was removed, and the
agarose was washed four times with PBS containing 0.1%
dodecylmaltoside. Bound proteins were eluted with a solu-
tion of 0.2 M glycine-HCl, pH 2.5, and neutralized with a
1 M Tris solution to a final concentration of ca. 130 mM.
Results
Mitochondrial protein methyltransferases
Previously, a catalogue of known and predicted
methyltransferases in human mitochondria has been
presented [23]. The entries were selected from a larger
catalogue of 208 known and putative methyltrans-
ferases [25] on the basis of their having an N-terminal
sequence with the characteristic features of a mito-
chondrial targeting signal that would be removed by
proteolysis during import of the protein into the orga-
nelle, to generate the mature protein in the matrix of
the mitochondrion [38]. This past catalogue contained
not only known protein methyltransferases but also
methyltransferases that modify RNA, and others
involved in the biogenesis of small molecules. The new
catalogue presented here (Table 1) is restricted to
known protein methyltransferases and unknown pre-
dicted methyltransferases. Thus, potentially, some
unknown entries could modify proteins, and others
either RNA or small molecules. Four proteins,
PRMT8, PRMT9, PRDM15 and KMT2A, are all pre-
dicted by two programs to be mitochondrial proteins,
but PRMT8 is a plasma membrane protein [39] and
the others are found in the nucleus and/or have been
shown to methylate nuclear proteins [40–43]. There-
fore, they have been excluded from the new catalogue.
Another potential methyltransferase, SETD4, has been
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described as being a component of both the nucleus
and the cytoplasm [44]. As the cytoplasmic attribution
could conceivably represent the mitochondria, SETD4
remains in this new restricted catalogue.
Overexpression of METTL12 and methylation of
human citrate synthase
METTL12, was overexpressed in HEK293T cells, and,
in comparison to an equivalent cell line overexpressing
a second mitochondrial methyltransferase, METTL20,
that modifies two lysine residues in ETFb [11,45], the
overexpression of METTL12 was accompanied by an
increase in the methylation of a lysine residue (or resi-
dues) in citrate synthase (Fig. 1). In order to identify
the methylated site or sites, peptides in AspN and
trypsin digests of human citrate synthase were anal-
ysed by mass spectrometry from the samples where
METTL12 and METTL20 had been overexpressed
(Tables S1–S4). The numbering of residues in the
sequence of citrate synthase refers to the mature pro-
tein produced by removal of the N-terminal 27 amino
acid MTS [10]. The fragmentation spectra of two triply
charged ions of an AspN peptide corresponding to
residues 363–374, with m/z values of 470.59 and
456.57, correspond to trimethylated and unmethylated
states respectively. These fragmentation spectra con-
tained the ions c5-c6 and z6-z7, which show that residue
Lys-368 is trimethylated (Fig. 1), whereas the ions c3-
c4 and z8-z9 show Lys-366 is unmodified. From the rel-
ative abundances of the mono-, di- and trimethylated
forms of the peptide (Table S5), it was calculated that
99% of this residue was trimethylated in cells
overexpressing METTL12, in contrast to 14.7% of the
residue being trimethylated in control cells. In the
same control cells, the abundances of dimethylated,
monomethylated and unmethylated states were 14.6%,
26.4% and 44.3% respectively (Fig. 1). Similar levels
of partial methylation of this site were observed in
cells overexpressing METTL20 (Fig. 1), which has no
effect on citrate synthase, but instead modifies two
lysine residues in ETFb [11,45].
Impact of disruption of METTL12
The 240 amino acids of the mitochondrial precursor of
human METTL12 are encoded by a single human gene
on chromosome 11 with three exons interrupted by
two introns. In the near-haploid human cell line
HAP1-DMETTL12, exon III has been disrupted by
the insertion of a single base. This insertion introduces
a frame-shift, leading to a truncated version of
METTL12 with the N-terminal mitochondrial import
sequence from residues 1–21 [29] and residues 1–30 of
the mature protein, plus unrelated protein sequence
terminated 66 amino acids later. Analysis of the mito-
plasts from wild-type HAP1 cells, revealed the
expected presence of the three prominent mitochon-
drial proteins containing trimethyllysine residues,
namely citrate synthase, the ADP/ATP translocase and
the c-subunit of ATP synthase. Similarly, the mito-
plasts from HAP1-DMETTL12 cells also contained the
trimethylated ADP/ATP translocase and the c-subunit
of ATP synthase, and the same level of citrate syn-
thase as wild-type cells, but in contrast to the wild-
type cells, the HAP1-DMETTL12 cells were devoid of
the trimethylated form of citrate synthase (Fig. 2A).
Table 1. Known and possible protein methyltransferases in human mitochondria.
Protein Familya MTSb Functionc Targetd Locatione References
HEMK1 7b 1 Gln-Me PRF1-L M [21,63]
METTL12 7b 3 Lys-Me CS M This work
METTL20 7b 3 Lys-Me ETFb M [11,45]
NDUFAF5 7b 4 Arg-OH NDUFS7 M [24,61,63]
NDUFAF7 7b 4 Arg-Me NDUFS2 M [23,62,63]
SETD9 SET 4 Unknown Unknown M [64]
RSAD1 R-SAM 4 Unknown Unknown M [64]
COMTD1 7b 1 Unknown Unknown M [63]
SETD4 SET 2 Unknown Unknown N, C [44]
METTL9 7b 4 Unknown Unknown Unknown
ASMTL 7b 3 Unknown Unknown Unknown
RRNAD1 7b 4 Unknown Unknown Unknown
a7b, 7b-strand; SET, SET domain (Drosophila Su(var)3-9, Enhancer of zeste and Trithorax); R-SAM, radical S-adenosylmethionine. bMTS,
number of independent predictions of the presence of a N-terminal mitochondrial targeting sequence; unless there is experimental evidence
for their localization in mitochondria, singly predicted proteins have been excluded. cGln-Me, Lys-Me and Arg-Me, glutamine, lysine and argi-
nine methyltransferases respectively; Arg-OH, arginine hydroxylase. dPRF1-L, peptide release factor 1-like; ETFb, the b-subunit of the elec-
tron transfer flavoprotein; CS, citrate synthase. eSubcellular location of methyltransferase; M, mitochondria; N, nucleus; C, cytoplasm.
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Both samples also contained additional bands, corre-
sponding to contaminant nonmitochondrial HSP70
proteins and elongation factor 1a, which also contain
trimethylated lysines [46,47].
The methylation of Lys-368 of citrate synthase in
wild-type HAP1 cells was verified by mass spectromet-
ric analysis of the AspN peptide from residues 363–
374. This analysis revealed that 74% of the peptide
was trimethylated, 10% was dimethylated, 9% was
monomethylated and 7% was unmethylated (Fig. 2
and Table S6). In contrast, in HAP1-DMETTL12 cells,
the level of the unmethylated peptide was 97% (Fig. 2
and Table S6). The residual 3% was predominantly
monomethylated, probably arising from artefactual
methyl esterification of residue Glu-363 by acidic
methanol used in the detection of the protein in the
SDS/PAGE gel [48]. Spectra arising from the fragmen-
tation of triply charged ions of this peptide with m/z
B
M
et
hy
la
tio
n 
le
ve
l (
%
)
20
25
37
50
75
CS
kDa
ETFβ
ANT
A
0
20
40
60
80
100
0
100
200 400 600 800 1000 1200 1400
m/z
(M+3H)3+ (M+3H)2+
332.16
c3 460.25
c4
(M+3H-17)2+
531.29
c5
c10
2+
598.33 655.35
701.43
c6
880.48
z7
951.52
z8
z9
1079.61
z10
1195.65
c10
z11
(M+3H-17)1+
(M+3H)1+
1411.77
c-ions
z-ions
114 5 6
E Q G K A K(me3) N P W P N V
3 10
11 789 610
c2
2
z10
2+
c11
2+
z11
2+
z6
y5
C
200 400 600 800 1000 1200 1400
m/z
0
100
(M+3H)3+
(M+3H)2+
332.16
c3
455.22
531.29
c5
460.25
c4
634.33
659.38
c6
(M+3H-17)2+
710.34
z6
838.44
z7
909.47
z8
1037.56
z9 (M+3H)
1+
1369.72
(M+3H-17)1+
c-ions
z-ions
114 5 6
E Q G K A K N P W P N V
3 10
11 789 6
c10
2+
c11
2+
z11
2+
D
%
%
a b c
a b c
470.59 705.88
684.86
456.57
EF1-α
HSP70
z8
2+
*
* y8
*
*
Fig. 1. The methylation of human citrate synthase accompanying overexpression of METTL12. (A) Fractionation by SDS/PAGE of
mitochondria from HEK293T cells overexpressing, in track a, METTL12, and in tracks b and c, METTL20. Proteins in tracks a and b
were detected with an antibody recognizing methylated lysine residues, and track c is track b, stripped of bound antibodies and
reprobed with antibodies against citrate synthase (CS) and ETFb. The positions of the proteins containing trimethylated lysine residues
are indicated on the left; HSP70, 70-kDa heat shock protein; EF1a, elongation factor 1a; ANT, ADP/ATP translocase. (B) The relative
peak areas taken from the extracted ion chromatograms of the AspN peptide EQGKAKNPWPNV (residues 363–374) of citrate synthase
in mitoplast samples, containing unmethylated, and mono-, di- and trimethylated lysine-368 residues (white, light grey, dark grey and
black areas respectively). Column a, control cells; b and c, cells overexpressing METTL20 and METTL12 respectively. (C,D)
Fragmentation spectra of the AspN peptide produced by ETD of triply charged ions with m/z 470.59 and 456.57 respectively. The
asterisks indicate ions arising from neutral losses of CH3NO and C2H5NO from Gln and Asn residues. In the insets, fragment ions
have been mapped onto the amino acid sequence.
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values of 456.57 and 470.59, confirmed the presence of
unmethylated forms of Lys-368 in HAP1-DMETTL12
cells and of trimethylated forms in HAP1 parental cells
(Fig. 2).
Impact of the absence of METTL12 on HAP1 cells
Under the limited range of conditions that were investi-
gated, the removal of METTL12 had no impact on the
proliferation of HAP1 cells (Fig. 3A). Additionally, nei-
ther the amount (wild-type, 0.13  0.03 and HAP1-
DMETTL12 0.14  0.02 nglg1 of cell lysate), nor the
enzymic activity of citrate synthase (Fig. 3) was affected.
Discussion
Subcellular site of methylation of mitochondrial
proteins
Nuclear-encoded mitochondrial proteins are synthe-
sized in the cytoplasm and are transferred to the orga-
nelle via TOM and TIM complexes in the outer and
inner membranes respectively [38]. Thus, it is conceiv-
able that the post-translational introduction of methyl
groups into specific mitochondrial proteins by methyl-
transferases could occur at any stage during their tran-
sit to their final destinations in the organelle.
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Fig. 2. Effect of disruption of METTL12 on the methylation of human citrate synthase. (A) Mitoplasts from a, wild-type HAP1 cells and
b, HAP1-DMETTL12 cells, fractionated by SDS/PAGE and western blotted with antibodies against trimethyllysine (TML) and citrate
synthase (CS). An antibody against malate dehydrogenase (MDH2), which is found in the matrix of mitochondria, provided a loading
control. On the right-hand side, the same membrane stained with Coomassie Blue dye. (B) The relative peak areas obtained from the
extracted ion chromatograms of the various methylation states of the AspN peptide representing residues 363–374 of citrate synthase.
The peptide was produced by digestion of the appropriate band in the fractionated mitoplast samples. Columns a and b, respectively,
wild-type and HAP1-DMETTL12 cells. For the meaning of the various shades, see the legend to Fig. 1. (C,D) ETD fragmentation
spectra of the AspN peptide from residues 363–374 from citrate synthase immunocaptured from mitochondria from HAP1 wild-type
and HAP1-DMETTL12 cells; they represent the trimethylated and unmethylated forms of the peptide respectively. The asterisks indicate
ions arising from neutral losses of CH3NO and C2H5NO from Gln and Asn residues. In the insets, fragment ions have been mapped
onto the amino acid sequence.
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Previously, in human mitochondria, three methyltrans-
ferases (HEMK1, NDUFAF7, METTL20), with SAM
as the methyl donor, have been found uniquely in the
matrix space (Table 1) [11,21,23]. In addition, NDU-
FAF5, which probably uses SAM as a cofactor in the
introduction of a hydroxyl group into the side chain
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Fig. 4. The predicted structure of human METTL12. (A) Predicted secondary structure of mature METTL12. The locations of a-helices indicated
above the sequence by red or green bars, and b-sheets by blue arrows. Helix Z, b-sheets 1-7 and intervening a-helices A-E characterize the 7b-
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helices and joining loops respectively. The positions of the substrate binding sites are shown.
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of Arg-73 in the NDUFS7 subunit of complex I, is
found in the same subcellular location [24]. METTL12,
also located in the mitochondrial matrix, adds a fourth
protein-modifying methyltransferase to this growing
list. Its predicted secondary structure indicates that it
is a 7b-strand methyltransferase with five of the six
associated canonical a-helices (Fig. 4). METTL12 has
been placed into a subfamily of 7b-strand methyltrans-
ferases, with human METTL10, METTL13 and
ECE2, and yeast EFM4 [25]. They share regions of
sequence homology including a postmotif-II sequence
that interacts with the specific substrate [49]. Like
METTL12, both METTL10 and EFM4 are lysine
methyltransferases [50,51]. Therefore, it is likely that
members of this subfamily all catalyse the methylation
of lysine residues.
The site of methylation in citrate synthase
The three-dimensional structure of human citrate syn-
thase has not been determined, but the sequences of
the human and porcine enzymes are 98% identical,
and therefore the structure of the porcine enzyme [52]
provides an excellent model for the human orthologue.
It is known that, as in the human enzyme, Lys-368 in
the porcine protein is trimethylated [10]. The active
enzyme is a homodimer, and Lys-368 is exposed on
the surface of the enzyme in a loop in an extended
structure that forms part of the binding pocket for
CoA (Fig. 5). Lys-366, nearby, is unmodified. Despite
the modified residue being close to the active site of
the enzyme, removal of the methyl group had no effect
on the activity of the human enzyme in vitro (Fig. 3),
and recombinant porcine citrate synthase lacking the
methylation had a similar specific activity to the
methylated enzyme isolated from a natural source [53].
However, this is unlikely to reflect the in vivo situation
in the mitochondrial matrix, where citrate synthase
does not function in isolation, but as a component of
the TCA cycle of enzymes. Moreover, while the
removal of the methyl groups in HAP1-DMETTL12
cells had no effect on cellular growth under the condi-
tions that were investigated (Fig. 3); in the high-glu-
cose IMDM media, HAP1 cells can use aerobic
glycolysis to generate the ATP and metabolites needed
for growth. Therefore, under these conditions, the
impact of any altered activity of citrate synthase on
cell growth will be minimal.
In contrast to the observed methylation, there was
no evidence for the acetylation of lysine residues of
citrate synthase in the mass spectrometric analysis of
AspN or tryptic peptides (Tables S1–S4 and S7–S10).
The equivalent concentrations of citrate synthase
measured in HAP1 cells, despite there being signifi-
cantly different levels of methylation, suggest that the
modification does not influence the stability of the
enzyme. However, the central location of the methy-
lated site, its conservation throughout metazoans, and
also in fungi and plants (Fig. 6), and the conserva-
tion of METTL12 across metazoans suggests that the
modification is likely to be biologically significant.
Citrate synthase catalyses the first step of the tri-
carboxylic acid cycle, and there is extensive evidence
that it forms a metabolon or metabolons with other
citric acid cycle enzymes to facilitate the channelling
of substrates between enzymes in the same pathway
[54–57]. One proposal is that all of the enzymes that
perform the cycle, plus aspartate aminotransferase
and nucleoside diphosphate kinase, are organized
around the a-ketoglutarate dehydrogenase complex
[58]. Therefore, one possibility is that under particu-
lar cellular conditions, as yet undefined, the methyla-
tion of Lys-368 regulates contacts with other
enzymes in a metabolon of part or all of the citric
acid cycle.
K368
K366
CoA
H274 D375
CIT
H320
Fig. 5. Location of methylated lysine-368 in citrate synthase. The
image, made with PyMol and shown in cartoon representation,
displays the active site of one monomer of the dimeric porcine
enzyme (PDB 2CTS). The CoA molecule is pink, and the side chain
of the trimethylated Lys-368 is red. The side chain of unmethylated
Lys-366 is blue. In addition to CoA, the active site also contains
citrate (CIT, green). Amino acids H274, H320 and D375 participate
in catalysis.
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Roles of methylation of mitochondrial proteins
Methylated proteins in mitochondria fall into two broad
categories. In the first are ETFb, where lysine residues
199 and 202 are methylated [11,45], and citrate synthase
described here. A characteristic of these proteins is that
the extent of methylation is partial, and in the case of at
least ETFb, it varies according to growth conditions. In
ETFb, the modified site is adjacent to the recognition
loop of the ETF, which has the remarkable property of
recognizing and binding to as many as 13 different acyl-
CoA dehydrogenases so as to allow electron transfer
between the dehydrogenases and the ETF [59,60]. It has
been postulated that methylation of ETFb helps to regu-
late these protein–protein interactions [11,45], similar to
one of the proposals being made here to explain the
methylation of citrate synthase. Unlike regulation of
pathways in other subcellular locations of human cells,
there is no evidence in mitochondria that methylation is
a reversible process, and so far, no mitochondrial
protein demethylase has been identified. The second cat-
egory consists of proteins where the site of methylation
is modified completely, as in Arg-85 of the NDUFS2
subunit of complex I [14], ADP/ATP translocase [12]
and the c-subunit of the ATP synthase complex [13]. To
this category, the complex I subunit, NDUFS7, can be
added, where Arg-73 is completely hydroxylated by
NDUFAF5 [14,24]. In the cases of NDUFS2 and
NDUFS7, the modifications are absolutely required in
the process of assembly of complex I, and, in each case,
the absence of the modification stalls the assembly pro-
cess at specific intermediate stages [23,24,61,62]. There-
fore, it is possible that, in the ADP/ATP translocase
and the c-subunit of the ATP synthase, the complete
methylation of the modified residues is also an obliga-
tory step in the biogenesis and/or assembly of the pro-
teins. The identification of the modifying enzymes
would help in the testing of this hypothesis.
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